Macrophages play critical roles in immunity, development, tissue repair, and cancer, but studies of their function have been hampered by poorly-differentiated tumor cell lines and genetically-intractable primary cells. Here we report a facile system for genome editing in non-transformed macrophages by differentiating ER-Hoxb8 myeloid progenitors from Cas9-expressing transgenic mice. These conditionally immortalized macrophages (CIMs) retain characteristics of primary macrophages derived from the bone marrow yet allow for easy genetic manipulation and a virtually unlimited supply of cells. We demonstrate the utility of this system for dissection of host genetics during intracellular bacterial infection using two important human pathogens: Listeria monocytogenes and Mycobacterium tuberculosis.https://doi.org/10.7554/eLife.45957.001
Although CRISPR/Cas9 technology has revolutionized our ability to manipulate genomes, cell-type specific barriers hinder genetic approaches to study many important mammalian cells and tissues. Macrophages are critical innate immune cells involved in tissue development, repair, and homeostasis as well as many microbial infections, but they are difficult to genetically manipulate via transfection or transduction, most likely due to sensitive circuits that sense foreign nucleic acid. Although it is possible to manipulate primary bone marrow derived macrophages (BMMs) using CRISPR/Cas9 technology (Chu et al., 2016), the low transduction and transfection efficiencies observed in these cells results in low editing efficiency or, if transductants can be selected, low cell numbers. These limited cell numbers preclude many biochemical and screening approaches that require many millions of cells. In addition, the short life-span of these cells does not allow for selection of individual mutant clones or subsequent genetic manipulations such as knockout of a second gene or protein overexpression. Because of these limitations many studies rely on either immortalized macrophage-like cell lines, which do not recapitulate important metabolic and inflammatory pathways of primary cells (Andreu et al., 2017), or the time-consuming process of generating transgenic or knockout mice from which to obtain BMMs.
To create an efficient and scalable system for effective genome editing in murine macrophages, we sought to build upon previous studies demonstrating that ectopic expression of an estrogen-regulated version of the homeobox transcription factor Hoxb8 (ER-Hoxb8) can immortalize macrophage progenitors that are self-renewing in the presence of β-estradiol (Knoepfler et al., 2001). Subsequent removal of the hormone activates normal differentiation of these cells into macrophages (Wang et al., 2006) (Figure 1—figure supplement 1a). We envisioned that deriving conditionally immortalized macrophage progenitors from Cas9-expressing mice (Platt et al., 2014) would allow us to perform gene editing in conditionally immortalized cells prior to differentiation, providing the opportunity to cryopreserve either bulk populations or individually-cloned mutant cells. Subsequent differentiation of edited progenitors into macrophages would then generate a theoretically unlimited supply of mutant macrophages for functional studies (Figure 1a). While others have recently taken a similar but limited approach using other lineages of Hoxb8 conditionally immortalized immune cells, we sought to fully establish the efficacy of Cas9+ CIMs for robust gene editing and infection of macrophages (Di Ceglie et al., 2017; Lee et al., 2017; MacDuff et al., 2018).
To this end, we harvested hematopoietic stem cells from mice that constitutively express Cas9, infected them with lentivirus expressing the ER-Hoxb8 fusion protein and selected for cells that survived 3–4 weeks of culture in the presence of β-estradiol, as described by Wang, et. al. (Wang et al., 2006). These Cas9+ macrophage progenitors grew robustly in suspension and, upon removal of β-estradiol and addition of MCSF, differentiated into adherent cells that expressed F4/80, a marker of macrophages (Figure 1—figure supplement 1b and c) (Rosas et al., 2011). However, in our initial studies we noted an unusual morphology of this initial population when compared to primary BMMs derived from wild-type C57BL/6 mice (Figure 1—figure supplement 1b); in addition, the cells expressed high levels of CD11c, a cell surface marker more closely associated with dendritic cells (Figure 1—figure supplement 1c). By re-selecting progenitors with high concentrations of the antibiotic G418, the resulting cell population more closely resembled BMMs morphologically (Figure 1—figure supplement 1a and b) and expressed lower levels of CD11c (Figure 1—figure supplement 1c). We speculate that high concentrations of G418 selected for progenitors with greater expression of the Hoxb8 fusion protein, skewing these cells towards a more uniform macrophage-committed progenitor population. Comparison of gross cellular morphology indicates that these Cas9+ CIMs are much more similar to BMMs than transformed macrophage-like lines such as the frequently used RAW 264.7 (Figure 1b). To more globally compare BMMs and CIMs, we used Nanostring technology to measure mRNA levels of over 700 genes associated with myeloid innate immunity and compared the gene expression pattern between the two cell types. While the level of some of these mRNAs were different between BMMs and CIMs, the majority of transcripts were present at remarkably similar levels in both cell populations, consistent with the initial studies of similarly differentiated ER-HoxB8 cells, which demonstrated that these cells express many macrophage-specific genes but did not compare them directly to BMMs (Figure 1c) (Wang et al., 2006).
To determine if Cas9+, gRNA-expressing CIMs possess functional macrophage phenotypes, we infected progenitors with one of three lentiviruses expressing non-targeting scramble gRNAs, selected transductants using puromycin, differentiated the resulting cells, and probed three macrophage characteristics to compare them with BMMs. First, flow cytometric analysis using key myeloid/lymphoid lineage markers revealed that CIMs were indistinguishable from BMMs, with high expression of the myeloid marker CD11b and macrophage marker F4/80, and low expression of CD11c, the monocyte marker Ly6C, and the neutrophil marker Ly6G (Figure 1d). Second, treatment with either lipopolysaccharide (LPS) (which engages TLR4) or CpG DNA (TLR9 agonist) induced the pro-inflammatory cytokines IL-6 and IL-12p40 from both CIMs and BMMs (Figure 1e). Although the levels were slightly different between the two cell types at these time points, it is clear that CIMs responded vigorously to innate immune stimulation upon engagement of pattern recognition receptors. Finally, CIMs and BMMs upregulated iNOS and generated similar levels of nitric oxide in response to stimulation with LPS plus interferon-γ (IFNγ) (Figure 1h and i). Based on these results, we conclude that transduced Cas9+ CIMs share many of the characteristics of BMMs.
To broadly assess genome editing efficacy in Cas9+ CIMs, we introduced 40 individual gRNAs targeting a total of 17 genes into these cells, selected for puromycin resistant cells, and assessed genome editing in the resulting populations by PCR amplification of the target sites and sequence analysis using Tracking Indels by Decomposition (TIDE) analysis (Brinkman et al., 2014). We found that over 80% of these gRNA transductions resulted in at least 70% editing of the target gene after differentiation, with the majority achieving 80–100% editing efficiency (Figure 1f). For all 11 genes independently targeted with three distinct gRNAs, we obtained >80% editing from at least one guide RNA. To test whether genome editing in these polyclonal populations resulted in significant differences in protein levels, we examined surface expression of CD11b and IFNγ receptor after transduction with gRNAs targeting CD11b or Ifngr1 and found that over 90% of CIMs had substantially reduced expression of the targeted protein as assessed by flow cytometry (Figure 1g). Likewise, transduction with lentiviruses encoding one of three separate guides targeting Nos2, the gene encoding the inducible nitric oxide synthase (iNOS), effectively blocked iNOS expression (Figure 1h) and production of NO (Figure 1i) in response to LPS + IFNγ in all three CIM populations. Although gene-to-gene variability in CRISPR/Cas9-mediated targeting efficiency will certainly exist, taken together our data indicate that independent transduction with three distinct gRNAs per gene in Cas9+ CIMs will disrupt the majority of genes efficiently enough to produce phenotypically relevant changes in gene expression using bulk populations of transduced cells.
Another major advantage of the Cas9+ CIM system is its potential for studying genetic interactions by generating double gene knockouts in the immortalized progenitor state prior to differentiation. To this end, we transduced Cas9+ macrophage progenitors with a lentivirus containing puromycin resistance and targeting Ifngr1 and subsequently transduced the resulting population with lentiviruses containing hygromycin resistance and expressing one of three CD11b or scramble guides. After differentiation of these doubly-resistant populations, over 90% of CIMs lacked both IFNγR1 and CD11b protein expression as assessed by flow cytometry (Figure 1j). This iterative approach provides a robust way to generate double knockouts, enabling a simple methodology to elucidate synthetic interactions. Overall, our results establish Cas9+ CIMs as an efficient and robust model for genome editing in macrophages with distinct advantages to standard transformed macrophage-like cell lines.
To more specifically test whether CIMs are effective for studying the antimicrobial functions of macrophages, we assessed the host and microbe requirements of two well-established bacterial pathogens that naturally infect macrophages, Listeria monocytogenes and Mycobacterium tuberculosis. First, L. monocytogenes incubated with either BMMs or CIMs were effectively phagocytosed, replicated robustly, and spread to neighboring macrophages (Figure 2a and c). After phagocytosis, L. monocytogenes ruptures phagosomal membranes using its secreted pore-forming toxin listeriolysin O (LLO, encoded by the hly gene) in order to grow in the cytosol, and expresses ActA to hijack the host actin polymerization machinery in order to propel itself through the cytosol and mediate spread to neighboring cells (Portnoy et al., 2002). Importantly, L. monocytogenes lacking LLO (Δhly) were unable to grow in BMMs or CIMs, and bacteria lacking ActA (ΔactA) failed to recruit actin and spread (Figure 2b). Thus, the major bacterial virulence determinants required for L. monocytogenes infection are the same for BMMs and CIMs.
Targeting microbes for destruction via the host autophagy pathway, a process termed xenophagy, is a major mechanism employed by primary macrophages for controlling intracellular pathogens, including L. monocytogenes (Gomes and Dikic, 2014). To determine whether CIMs are capable of restricting L. monocytogenes through autophagy targeting, we used a previously characterized bacterial mutant strain lacking three key virulence factors (ActA, PlcA, PlcB) required for microbial evasion of autophagy in BMMs (Mitchell et al., 2018). Kinetic growth assays revealed that this autophagy-sensitive L. monocytogenes strain, and the LLO-defective L. monocytogenes mutant, are both significantly attenuated in both BMMs and CIMs (Figure 2c). Bacterial burden associated with all three strains of L. monocytogenes was somewhat reduced in CIMs compared to BMMs, which we speculate is due to enhanced early killing by the phagolysosomal pathway. Similar results have been observed in peritoneal macrophages, which more effectively engage LC3-associated phagocytosis and are more microbicidal than BMMs against L. monocytogenes early in infection (Gluschko et al., 2018; Herskovits et al., 2007). To examine host genetics of microbial autophagy targeting, we generated CIMs deficient in one of several key components of the autophagy pathway and subsequently infected them with WT L. monocytogenes and the autophagy-sensitive strain. Abrogation of the autophagy pathway through knockout of Atg5, Atg7, or Atg16l1 restored replication of the autophagy-sensitive L. monocytogenes strain relative to scramble CIM controls (Figure 2d), demonstrating that xenophagic targeting is intact and functional in CIMs.
Mycobacterium tuberculosis is a major human pathogen and its ability to replicate and persist within macrophages, as well as to interact with the adaptive immune system, is central to its long-term pathogenic strategy (Upadhyay et al., 2018). Its most important virulence determinant is the type VII protein secretion system termed ESX-1, which is critical for growth in macrophages and influences the innate immune responses of these cells (Stanley et al., 2003). To assess CIMs as a model for studying M. tuberculosis invasion of macrophages, we infected BMMs and CIMs with auto-luminescent M. tuberculosis strains and quantified bacterial replication over a five-day time course. We found that wild-type M. tuberculosis grew robustly in CIMs, with kinetics comparable to that observed in BMMs (Figure 3a). CIM monolayers began to lose integrity six days after infection as the macrophages initiated cell death, a hallmark of M. tuberculosis infection (Chen et al., 2008), which occurred slightly earlier than in BMM monolayers (data not shown). To determine whether ESX-1 is required for M. tuberculosis replication in CIMs, we also infected both macrophage types with an auto-luminescent M. tuberculosis strain lacking the core ATPase for the secretion system, eccC, which results in complete loss of ESX-1 secretion (Rosenberg et al., 2015). As expected, these mutant bacteria were unable to replicate in BMMs or CIMs, indicating that the requirements for M. tuberculosis replication are the same for both types of macrophages (Figure 3a).
IFNγ-mediated activation of macrophage antimicrobial defenses during in vivo infection is critical for host resistance to M. tuberculosis infection, and ex vivo treatment of cultured macrophages with this cytokine induces BMMs to inhibit bacterial replication (Flynn et al., 1993). Importantly, addition of IFNγ to CIMs transduced with lentivirus encoding scramble gRNA restricted M. tuberculosis growth to a similar extent as IFNγ treated BMMs (Figure 3b). Abrogating IFNγ signaling through knockout of Ifngr1 (Figure 1g) restored replication of M. tuberculosis in IFNγ treated CIMs (Figure 3b). These data indicate that CIMs can provide the environmental conditions required for M. tuberculosis growth, but also have the inducible capacity to restrict bacterial replication.
Macrophage-like cell lines and BMMs have been demonstrated to induce markedly different responses after M. tuberculosis infection (Andreu et al., 2017). To determine how closely CIMs resemble BMMs during infection with M. tuberculosis, we globally compared gene expression of BMMs and CIMs during infection with either a virulent WT M. tuberculosis Erdman strain or M. tuberculosis ΔeccC lacking a functional ESX-1 secretion system using the same 700 myeloid gene panel as described above. There was strong correlation between the genes induced by BMMs and CIMs in response to both WT and ΔeccC M. tuberculosis (Figure 3c and d). Lentiviral transduction with a non-targeting gRNA did not significantly alter the response of CIMs to M. tuberculosis (Figure 3—figure supplement 1a). In contrast to the comparison between BMMs and CIMs, there was weak correlation between the genes induced by RAW 264.7 cells and BMMs or CIMs in response to M. tuberculosis (Figure 3—figure supplement 1b and c). Both BMMs and CIMs activated genes known to be involved in M. tuberculosis infection, including Cd40, Il1b, Nos2, Ptgs2, Tlr2, and Tnf (Andreu et al., 2017) (Figure 3e). As previously demonstrated in BMMs, we observed that many interferon-stimulated genes were more highly induced upon infection with WT M. tuberculosis than M. tuberculosis lacking ESX-1 in both BMMs and CIMs (Manzanillo et al., 2012; Stanley et al., 2007) (Figure 3f). Overall, these results establish CIMs as a suitable model for M. tuberculosis infection of macrophages.
Our results establish Cas9+ CIMs as a powerful ex vivo model of macrophage biology and represent a major technological advance in our ability to capitalize on powerful genome editing capabilities in this notoriously refractory cell type. We expect that the methods we have developed will lay the foundation for investigations exploring new pathways that mediate the many roles of this important cell type in mammalian biology (Wynn et al., 2013). Indeed, while we show that Cas9+ CIMs are a flexible tool for studying some important aspects of innate immunity and inflammation, they are also likely to be useful for unbiased screening of CRISPR libraries to identify pathways important for other macrophage functions including tissue homeostasis and metabolic reprogramming. Because Cas9+ CIMs can give rise to an unlimited number of mutant macrophages, this scalable system can generate genetically defined mutant macrophages for use in a wide range of applications, from in vitro biochemical approaches to in vivo adoptive transfer studies of mice (Redecke et al., 2013; Wiesmeier et al., 2016). Furthermore, using an iterative genome-editing approach, Cas9+ CIMs allow for facile exploration of large-scale genetic interactions. Thus, this system represents a significant technological advance that will likely promote the study of macrophages and their myriad functions.
Bone marrow derived macrophages (BMMs) were generated from the femurs and tibias from wild-type C57BL/6 (The Jackson Laboratory) mice that were 8–12 weeks old. Conditionally-immortalized macrophages (CIMs) were derived from bone marrow cells from a 5-FU treated male Cas9+ mouse (Platt et al., 2014). Hoxb8 immortalized cells were generated as previously described (Wang et al., 2006) with the modification that progenitors in bone marrow were enriched by negative depletion; cells expressing CD11b, Ter119, B220, CD5, CD19, and Gr-1 were depleted using biotinylated antibodies and streptavidin coated dynabeads. For re-selection of CIM progenitors, cells were cultured in 10 mg/ml G418 for 7 days. All mice were housed in specific-pathogen free conditions and treated using procedures described in animal care protocols approved by the Institutional Animal Care and Use Committee of UC Berkeley.
Progenitor CIMs prior to differentiation were maintained in RPMI (Gibco) supplemented with 10% FBS, 2% GM-CSF supernatant produced by a B16 murine melanoma cell line, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 43 uM β-mercaptoethanol, and 2 uM β-estradiol (Sigma #E2758). Progenitor CIMs were maintained in suspension in non-treated tissue culture treated flasks at densities below 500,000 cells/ml before removal of β-estradiol and differentiation. BMMs and differentiated CIM macrophages were cultured in macrophage media: DMEM (Gibco) supplemented with 10% FBS, 10% M-CSF supernatant produced by 3T3-MCSF cells as previously described, 2 mM L-glutamine (Gibco), and 1 mM sodium pyruvate (Gibco). RAW 264.7 cells were cultured in DMEM (Gibco) supplemented with 10% FBS, 2 mM L-glutamine (Gibco), and 20 mM HEPES. To differentiate progenitor CIMs into macrophages, cells were washed twice in PBS + 1% FBS to fully remove β-estradiol, resuspended in complete macrophage media, and seeded onto non-treated 15 cm tissue culture plates at 5.0 × 106 cells/plate in 20 ml of media. Differentiating CIM macrophages were given an additional 10 ml of macrophage media on days 3 and 6 post-differentiation, and terminal assays were performed at day 9 or 10 post-differentiation.
CRISPR guide sequences targeting genes of interest were selected from the murine Brie guide library. Oligonucleotides encoding the chosen gRNAs (see Supplementary file 1) were cloned into pLentiGuide-Puro (Addgene #52963) or lenti-gRNA hygro (Addgene #104991), and verified by sequencing using the human U6 sequencing primer. 293 T cells were co-transfected with pLentiGuide-Puro, psPAX2, and pMD2.G using Lipofectamine and Optimem according to manufacturer's guidelines to generate lentiviral particles for trandsuction into Cas9-expressing CIM progenitors. For optimal transduction of Cas9-expressing CIM progenitors, 5.0 × 105 cells/well in a 6-well plate were spinfected at 1000xg for 2 hr at 32°C in the presence of 10 µg/ml protamine sulfate. Two days post-transduction, 12 µg/ml puromycin was added to cells, and cells were selected in puromycin for 4 days. Puromycin-resistant cells were maintained as polyclonal populations and total gDNA was extracted using DNeasy Blood and Tissue kit (Qiagen). To generate double knockout progenitors, puromycin-resistant progenitors that had previously been transduced with pLentiGuide-Puro were transduced with lenti-sgRNA hygro and selected using 250 µg/ml hygromycin for 8 days. The genomic sites encompassing targeted guide regions were amplified by PCR using iProof polymerase (BioRad) and sequenced, and population level genome editing was estimated using the TIDE webtool (https://tide.deskgen.com/) as originally described (Brinkman et al., 2014). Guide genome editing efficiencies displayed were a combination of data from CIMs before and after G418 selection, with no notable difference in editing efficiency caused by G418 selection.
CIMs or BMMs were seeded at 60,000 cells per well onto white, clear-bottom CellBind 96-well plates (Corning) or 12-well TC-treated plates (Corning) in macrophage media one or two days prior to infection. For pre-treatment of macrophages with IFN-γ, post-seeding cell culture media was switched to media with 1.5 ng/µl of recombinant murine IFN-γ (Peprotech) 12–18 hr prior to infection, and activated cells were subsequently cultured in IFN-γ containing media throughout infection.
Macrophages were infected with M. tuberculosis as previously described (Penn et al., 2018). The M. tuberculosis strain Erdman the ΔeccC strain made in the Erdman background, or the WT or ΔeccC strain made in the Erdman background expressing the luxCDABE operon (Braverman et al., 2016; Penn et al., 2018; Rosenberg et al., 2015) were used for all infections. All Mtb strains were cultured in 7H9 liquid media (BD) supplemented with 10% Middlebrook OADC (Sigma), 0.5% glycerol, 0.05% Tween-80 in roller bottles at 37°C. Briefly, mid-log M. tuberculosis cultures were washed twice with PBS, gently sonicated to disperse clumps, and resuspended in phagocytosis infection media (DMEM supplemented with 5% horse serum and 5% FBS). For luminescence assays macrophages were infected in at least triplicate wells by removing media from cells, and monolayers were overlaid with the bacterial suspensions in phagocytosis media then incubated at 37°C for 4 hr, after which infection media was removed and fresh macrophage media was added. Bacterial luminescence signal was measured at 32°C at the time of infection and every day starting 48 hr post-infection after daily media changes. All growth measurements are normalized to day 0 luminescence readings for each infected well and are presented as fold change in luminescence compared to day 0. Cells were infected at a multiplicity of infection (MOI) of 5 for RNA analysis and 0.5 for assays monitoring bacterial growth.
The WT 10403S, ΔactA (DP-L3078), Δhly (DP-L2161) and the autophagy-sensitive ΔactA PlcAH86A PlcBH69G (DP-L6586) strains (Mitchell et al., 2018) (Cheng et al., 2018) were grown overnight in brain heart infusion (BHI) medium at 30°C before each experiment. Infections of macrophages were performed as previously described (Cheng et al., 2018; Mitchell et al., 2018) with few modifications. BMMs and CIMs were seeded on round 12 mm coverslips (Fisher Scientific, Hampton, NH, USA) and incubated overnight at 37°C and 5% CO2. Coverslips were incubated with a solution 0.1% gelatin for 1 hr at 37°C and washed twice with PBS prior seeding CIMs. Macrophages were infected at various MOIs, washed at 0.5 hr post-infection and further incubated in fresh medium. At 1 hr post-infection, 50 µg/ml of gentamicin was added to the medium in order to kill extracellular bacteria. MOIs and incubation times are indicated in figure legends.
Cells were fixed with Fix/Perm buffer (BD) for 20 min at 4°C. All stains were carried out in PBS containing 2% FBS (v/v) including anti-CD16/32 Fc blocking antibody (clone 93, BioLegend). Cells were stained for 20 min at 4°C with antibodies against F4/80 (clone BM8, Tonbo Biosciences), CD11b (clone M1/70, Tonbo Biosciences), CD11c (clone N418, Tonbo Biosciences), Ly6C (clone HK 1.4, BioLegend), Ly6G (clone 1A8, Tonbo Biosciences), IFNγR1 (clone 200, eBioscience) or iNos (clone CXNFT, eBioscience). All cells were analyzed on an LSR Fortessa (BD Biosciences), and data was analyzed with FlowJo.
Cells were seeded at 60,000 cells per well in 96-well CellBind plates (Corning) in macrophage media the day prior to stimulation. For cytokine analysis cells were stimulated with 1 µg/ml LPS (InvivoGen) or 1 uM CpG-1668 (InvivoGen, Tlrl-1668) for 16–20 hr. Cell-free supernatants were harvested and frozen at −20°C prior to analysis. For Griess assay analysis, cells were stimulated with 100 ng/ml LPS and 5 ng/ml IFNγ. After 24 hr cell-free supernatant was harvested and immediately analyzed.
Cell-free supernatants from stimulated cells were analyzed by ELISA to enumerate cytokine production. Supernatants were absorbed onto a 96-well Nunc MaxiSorp flat-bottom plate (44-2404-21, Invitrogen) coated with the following capture antibodies diluted in 0.1M sodium phosphate buffer pH 8.0 and incubated overnight at 4°C: IL-6 (clone MP5-20F3, 554400, BD Biosciences, 1 μg/ml) and IL-12 p40 (clone C15.6, 14-7125-81, eBioscience, 1 μg/ml). The following day, plates were washed 3x with PBS + 0.05% Tween-20 and blocked with PBS + 1% BSA for 4 hr at RT. Recombinant cytokines for standard measurements were serially diluted in PBS/BSA. IL-6 (406 ML-025, R and D) IL-12 p40 (34-8321-63, eBioscience) and experimental supernatants were incubated overnight at 4°C. After 3X washes in PBS/BSA, biotin-conjugated sandwich antibodies were incubated on supernatants and standards (IL-6, MP5-32C11, 554402, BD Biosciences and p40 C17.8, 13-7123-85, eBiosciences) and detected by Streptavidin-HRP (BD Biosciences, 1:3000). For the development step, ELISA was incubated with OPD (Sigma) and 30% hydrogen peroxide, followed by incubation with 3M HCl. Absorbance at 490 nm was read on an Infinite M200 Tecan plate reader.
Cell-free supernatants from stimulated cells were analyzed by Griess reaction to detect nitrite as a proxy for NO production. A solution of 0.2% napthylethylenediamine dihydrochloride was mixed 1:1 with a 2% sulfanilamide/4% phosphoric acid solution. 100 µl of this solution was mixed with 100 µl of sample supernatant and absorbance at 546 nm was immediately measured. Nitrite concentrations were determined using a standard curve of sodium nitrite.
Coverslips seeded with macrophages were left uninfected or infected with L. monocytogenes, stained with a Diff-Quick stain set (Dade Behring, Deerfield, IL, USA), air-dried and mounted on glass slides using a drop of Permount (Fisher Scientific). Immunofluorescence staining of macrophages infected with L. monocytogenes was performed using a polyclonal rabbit antisera that recognizes L. monocytogenes (BD Biosciences, San Jose, CA, USA), a rhodamine red‐X goat anti‐rabbit IgG (Invitrogen, Carlsbad, CA, USA), phalloidin AlexaFluor‐647 (Invitrogen) and ProLong Gold antifade reagent containing 4′6,‐diamidino‐2‐phenylindole (Invitrogen), as previously described (Cheng et al., 2018). All images were acquired with a KEYENCE BZ‐X710 fluorescent microscope using a 100 × objective and post-treated using the haze reduction function of the BZ‐X analyser software. Images showed in Figure 2B were obtained by staking 10 layers covering 5 μm of thickness and pseudo-colored.
Total RNA was isolated using TRIzol (Fisher) and the PureLink RNA Mini Kit (12183018A, Ambion), NEB DNase treated, and purified using RNA clean and concentrator columns (Zymo). RNA was analyzed using the mouse myeloid innate immunity panel of the NanoString nCounter Analysis System (NanoString Technologies). Raw counts of samples were normalized according to the manufacturer’s recommendations using reference genes as internal controls (Sdha, Oaz1, Rpl19, Edc3, Sap130, Hdac3, Polr2a, Ppia, Gusb, Tbp, Sf3a3, and Abcf1). Background threshold was set to the geometric mean of the negative controls. Normalization was performed using nSolver Analysis Software v4. Normalized transcript counts are shown in Figure 3—source data 1.
Statistical analysis of data was performed using GraphPad Prism software (Graphpad, San Diego, CA). Results are reported as the mean ± SD. Pearson correlation coefficients and R2 values for scatter plots of mRNA expression were determined using log transformed data.
HIF-1α is an essential mediator of IFN-γ-dependent immunity to Mycobacterium tuberculosisThe Journal of Immunology 197:1287–1297.https://doi.org/10.4049/jimmunol.1600266
Easy quantitative assessment of genome editing by sequence trace decompositionNucleic Acids Research 42:e168.https://doi.org/10.1093/nar/gku936
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathThe Journal of Experimental Medicine 205:2791–2801.https://doi.org/10.1084/jem.20080767
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infectionJournal of Experimental Medicine 178:2249–2254.https://doi.org/10.1084/jem.178.6.2249
The metabolic regulator mTORC1 controls terminal myeloid differentiationScience Immunology 2:eaam6641.https://doi.org/10.1126/sciimmunol.aam6641
Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cellsEuropean Journal of Immunology 41:356–365.https://doi.org/10.1002/eji.201040962
Tuberculosis and the art of macrophage manipulationPathogens and Disease, 76, 10.1093/femspd/fty037, 29762680.
Wendy S GarrettSenior Editor; Harvard TH Chan School of Public Health, United States
Bavesh D KanaReviewing Editor; University of the Witwatersrand, South Africa
In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.
Thank you for submitting your article "Cas9+ Conditionally-Immortalized Macrophages: a tool for bacterial pathogenesis and beyond" for consideration by eLife. Your article has been reviewed by four peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Wendy Garrett as the Senior Editor. The reviewers have opted to remain anonymous.
The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.
The authors set out to create an approach that will yield a cell type that is close to primary bone marrow-derived macrophages (BMMs), and that can be (i) produced in abundance ex vivo and (ii) be genetically manipulated through CRISPR-CAS9 to modulate specific pathways. The cell type produced are referred to as Conditionally-Immortalized Macrophages (CIM).
Approach: They use a regulated version of the homeobox transcription factor Hoxb8 (ER-Hoxb8) in conditionally immortalized macrophage progenitors from Cas9-expressing mice, with the idea that differentiation of these can lead to unlimited supply of macrophages. By comparing the gross morphology of the resulting cells, the authors demonstrate similarity to BMMs, an observation further confirmed using NanoString technology to measure mRNA of
700 genes associated with myeloid innate immunity. The functionality (determined by measuring induction of pro-inflammatory cytokines IL-6 and IL-12p40 and measuring iNOS activity) and similarity of CIMs is maintained when these cells are transfected with the lentivirus system used to deliver short guide RNAs for gene knockdown. Next, to determine the capacity of these CIMs for gene editing the authors introduced 40 individual short guide RNAs that target 17 genes and assessed knockdown using Tracking Indels by Decomposition (TIDE) analysis. In this set of experiments, they obtained >80% gene knockdown from at least one guide RNA. Following this, they also develop a system to make double gene knockdowns in the CIM model.
Validation: To validate the utility of the CIMs produced by the authors, they use two bacterial systems, Listeria monocytogenes and Mycobacterium tuberculosis (with BMMs the comparator).
L. monocytogenes: Here they monitored phagocytosis and replication, which were comparable between the two cell types (CIMs and BMMs). They also monitored secretion of the listeriolysin O toxin and the ability of the bacterium to make actin comet tails, these bugs move around the cytoplasm by recruiting actin, through a protein called ActA. In addition, using mutants of L. monocytogenes and CIM gene knockdowns they confirmed the role for autophagy in controlling infection. All these processes were similar in CIMs and BMMs.
M. tuberculosis: Here, they infected BMMs and CIMs with auto-luminescent M. tuberculosis strains and looked at bacterial replication and report robust growth in CIMs with kinetics comparable to that of BMMs. To determine if CIMs could be used to explore the biology of tubercle bacteria, they assessed whether the specialized Esx secretion apparatus was important for replication in CIMS. For this, they use a M. tuberculosis strain lacking the core ATPase, required for this system, and report that the mutant bacteria were unable to replicate in BMMs or CIMs. Next, they explore the role of IFNγ and report similar outcomes between the two cell types. They also compared gene expression of BMMs and CIMs infected with wild type M. tuberculosis or a ΔeccC muant using the 700 gene panel described above. They find a strong correlation between genes expressed in CIMs and BMMs, thus confirming the utility of the CIM model for TB studies.
Key finding: The development of the Cas9+CIM system is a significant technological advance. It provides an invaluable tool for the study of macrophage biology and macrophage/pathogen interaction. Availability of this technology to the broader scientific community would help in the advancement of science.
1) One of the major concerns is choosing technical duplicates from one experiment for NanoString experiment. The authors should justify why they haven't performed biological replicates if they are not able to repeat the experiment in Figure 1C, Figure 3C, D.https://doi.org/10.7554/eLife.45957.011
1) One of the major concerns is choosing technical duplicates from one experiment for NanoString experiment. The authors should justify why they haven't performed biological replicates if they are not able to repeat the experiment in Figure 1C, Figure 3C, D.
We have confirmed the results from the original transcriptional profiling experiment with a biological replicate, using the same NanoString platform as the readout. This new data demonstrates that we are able to replicate this result precisely, indicating that two cell populations are indeed quite similar in their transcriptional profiles. Representative data from the two experiments is displayed in Figure 1C, Figure 3C,D, and all data is available in the Figure 3—source data 1. We were also able to compare the transcriptional profile of Mtb-infected RAW 264.7 cells with BMMs and CIMs and have included these data in Figure 3—figure supplement 1.https://doi.org/10.7554/eLife.45957.012
- Gregory M Barton
- Jeffery S Cox
- Gregory M Barton
- Jeffery S Cox
- Jeffery S Cox
- Gregory M Barton
- Allison W Roberts
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank Nevan J Krogan as well as members of the Cox, Barton, and Stanley labs for helpful discussions and advice. This work was supported by NIH Grants P01 AI063302 (JSC and GMB), U19 AI135990 (JSC and GMB), DP1 AI124619 (JSC), R01 AI072429 (GMB). Allison Roberts is an Open Philanthropy Fellow of the Life Sciences Research Foundation.
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All mice were treated using procedures described in animal care protocols approved by the Institutional Animal Care and Use Committee of UC Berkeley (Protocol # AUP-2015-11-8096-1).
- Wendy S Garrett, Harvard TH Chan School of Public Health, United States
- Bavesh D Kana, University of the Witwatersrand, South Africa
- Received: February 9, 2019
- Accepted: June 7, 2019
- Version of Record published: June 17, 2019 (version 1)
© 2019, Roberts et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
Exercise has a wide range of systemic effects. In animal models, repeated exertion reduces malignant tumor progression, and clinically, exercise can improve outcome for cancer patients. The etiology of the effects of exercise on tumor progression are unclear, as are the cellular actors involved. We show here that in mice, exercise-induced reduction in tumor growth is dependent on CD8+ T cells, and that metabolites produced in skeletal muscle and excreted into plasma at high levels during exertion in both mice and humans enhance the effector profile of CD8+ T-cells. We found that activated murine CD8+ T cells alter their central carbon metabolism in response to exertion in vivo, and that immune cells from trained mice are more potent antitumor effector cells when transferred into tumor-bearing untrained animals. These data demonstrate that CD8+ T cells are metabolically altered by exercise in a manner that acts to improve their antitumoral efficacy.
A small fraction of HIV-1- infected humans develop broadly neutralizing antibodies (bNAbs) against HIV-1 that protect macaques from simian immunodeficiency HIV chimeric virus (SHIV). Similarly, a small number of macaques infected with SHIVs develop broadly neutralizing serologic activity, but less is known about the nature of simian antibodies. Here, we report on a monoclonal antibody, Ab1485, isolated from a macaque infected with SHIVAD8 that developed broadly neutralizing serologic activity targeting the V3-glycan region of HIV-1 Env. Ab1485 neutralizes 38.1% of HIV-1 isolates in a 42-pseudovirus panel with a geometric mean IC50 of 0.055 µg/mLl and SHIVAD8 with an IC50 of 0.028 µg/mLl. Ab1485 binds the V3-glycan epitope in a glycan-dependent manner. A 3.5 Å cryo-electron microscopy structure of Ab1485 in complex with a native-like SOSIP Env trimer showed conserved contacts with the N332gp120 glycan and gp120 GDIR peptide motif, but in a distinct Env-binding orientation relative to human V3/N332gp120 glycan-targeting bNAbs. Intravenous infusion of Ab1485 protected macaques from a high dose challenge with SHIVAD8. We conclude that macaques can develop bNAbs against the V3-glycan patch that resemble human V3-glycan bNAbs.